Salivary Gland

The salivary glands are exocrine glands responsible for producing saliva, a complex fluid that plays multiple essential roles in oral health. The three pairs of major salivary glands are the parotid glands (located anterior to each ear), the submandibular glands (beneath the floor of the mouth along the mandible), and the sublingual glands (under the tongue). In addition, hundreds of minor salivary glands are distributed throughout the oral mucosa, including the palate, lips, and inner cheeks. Together, these glands produce approximately 0.5 to 1.5 liters of saliva daily, providing lubrication for speech and swallowing, initiating carbohydrate digestion through salivary amylase, buffering oral pH, delivering calcium and phosphate ions for tooth remineralization, and offering antimicrobial protection through immunoglobulin A, lysozyme, and lactoferrin.

Salivary gland disorders relevant to dental practice include xerostomia (dry mouth), sialadenitis (gland inflammation), sialolithiasis (salivary stones), and neoplasms. Xerostomia is by far the most commonly encountered condition, frequently resulting from medication side effects, radiation therapy to the head and neck, autoimmune diseases such as Sjogren syndrome, and systemic conditions including diabetes. Reduced salivary flow dramatically increases the risk of dental caries, particularly root caries and cervical lesions, accelerates periodontal disease progression, compromises denture retention, and causes significant patient discomfort. Clinical assessment of salivary function may include visual examination of gland duct openings, palpation of the glands, and measurement of stimulated and unstimulated salivary flow rates.

The impact of salivary gland dysfunction on the dental revenue cycle is substantial and often underappreciated. Patients with compromised salivary function require more frequent preventive visits, additional fluoride applications, and closer monitoring of restorations. These intensified protocols generate additional billable appointments that should be properly coded and documented with clear reference to the underlying salivary condition. Custom fluoride tray fabrication, prescription-strength fluoride products, and saliva substitutes all represent treatment components that can be appropriately billed. Furthermore, the increased caries susceptibility in these patients often leads to a higher volume of restorative procedures over time. Practices that identify and document salivary gland dysfunction early can build full treatment plans that serve both the patient's clinical needs and the practice's revenue goals while providing strong justification for any insurance inquiries regarding treatment frequency.